Publicaciones en las que colabora con GERMAN MORIS DE LA TASSA (19)

2022

  1. Smoking is associated with age at disease onset in Parkinson's disease

    Parkinsonism & related disorders, Vol. 97, pp. 79-83

2021

  1. Cancer in Parkinson's Disease: An Approximation to the Main Risk Factors

    Neurodegenerative Diseases, Vol. 21, Núm. 1-2, pp. 36-41

2014

  1. Alpha-synuclein transcript isoforms in three different brain regions from Parkinson's disease and healthy subjects in relation to the SNCA rs356165/rs11931074 polymorphisms

    Neuroscience Letters, Vol. 562, pp. 45-49

  2. MiRNA Profile in the Substantia Nigra of Parkinson’s Disease and Healthy Subjects

    Journal of Molecular Neuroscience, Vol. 54, Núm. 4, pp. 830-836

  3. The screening of the 3′UTR sequence of LRRK2 identified an association between the rs66737902 polymorphism and Parkinson's disease

    Journal of Human Genetics, Vol. 59, Núm. 6, pp. 346-348

2013

  1. Mutational screening of PARKIN identified a 3′ UTR variant (rs62637702) associated with parkinson's disease

    Journal of Molecular Neuroscience, Vol. 50, Núm. 2, pp. 264-269

  2. Profile of microRNAs in the plasma of Parkinson's disease patients and healthy controls

    Journal of Neurology

  3. SPG7 mutational screening in spastic paraplegia patients supports a dominant effect for some mutations and a pathogenic role for p.A510V

    Clinical Genetics, Vol. 83, Núm. 3, pp. 257-262

2012

  1. A search for SNCA 3′ UTR variants identified SNP rs356165 as a determinant of disease risk and onset age in Parkinson's disease

    Journal of Molecular Neuroscience, Vol. 47, Núm. 3, pp. 425-430

  2. Mitochondrial DNA polymorphisms/haplogroups in hereditary spastic paraplegia

    Journal of Neurology, Vol. 259, Núm. 2, pp. 246-250

2011

  1. Amyloid precursor protein gene (APP) variation in late-onset alzheimer's disease

    Journal of Molecular Neuroscience, Vol. 45, Núm. 1, pp. 5-9

  2. Lack of association between protocadherin 11-X/Y (PCDH11X and PCDH11Y) polymorphisms and late onset Alzheimer's disease

    Brain Research, Vol. 1383, pp. 252-256

  3. Late-onset Alzheimer's disease is associated with mitochondrial DNA 7028C/haplogroup H and D310 poly-C tract heteroplasmy

    Neurogenetics

2010

  1. Analysis of the micro-RNA-133 and PITX3 genes in Parkinson's disease

    American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, Vol. 153, Núm. 6, pp. 1234-1239

  2. FGF20 rs12720208 SNP and microRNA-433 variation: No association with Parkinson's disease in Spanish patients

    Neuroscience Letters, Vol. 479, Núm. 1, pp. 22-25

  3. Mutational spectrum of the SPG4 (SPAST) and SPG3A (ATL1) genes in Spanish patients with hereditary spastic paraplegia

    BMC Neurology, Vol. 10

1999

  1. Angiotensin converting enzyme and endothelial nitric oxide synthase DNA polymorphisms and late onset Alzheimer's disease

    Journal of Neurology Neurosurgery and Psychiatry, Vol. 67, Núm. 6, pp. 733-736

  2. Association between an α2 macroglobulin DNA polymorphism and late-onset Alzheimer's disease

    Biochemical and Biophysical Research Communications, Vol. 264, Núm. 1, pp. 48-50

  3. Frecuencia del alelo APOE-4 en la enfermedad de Alzheimer en la población asturiana y su variación con la edad

    Medicina Clinica, Vol. 113, Núm. 12, pp. 441-443